ORAGENICS, INC. Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
ORAGENICS, INC. (OGEN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 40.66 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-13
- ORAGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 40.79M shares, a 81139.02% increase year-over-year.
- ORAGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 50.22K shares, a 90.71% decline year-over-year.
- ORAGENICS, INC. antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 540.78K shares.
| Period end | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filed | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month |
|---|---|---|---|---|
| 2026-06-30 | 40.66M shares 10-Q · filed 2026-08-13 | |||
| 2026-03-31 | 40.79M shares 10-Q · filed 2026-05-08 | |||
| 2025-09-30 | 6.97M shares 10-Q · filed 2025-11-07 | |||
| 2025-06-30 | 43.47K shares 10-Q · filed 2026-08-13 | |||
| 2025-03-31 | 50.22K shares 10-Q · filed 2026-05-08 | 1.51M shares 10-Q · filed 2025-05-09 | ||
| 2024-09-30 | 19.06K shares 10-Q · filed 2025-11-07 | |||
| 2024-06-30 | 19.06K shares 10-Q · filed 2025-08-08 | |||
| 2024-03-31 | 540.78K shares 10-Q · filed 2025-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |